Responder Analysis For Fev1 Improvement With Dupilumab In Patients With Persistent Asthma And Elevated Eosinophil Levels

被引：0
|
作者：
Castro, M. [1 ]
Teper, A. [2 ]
Wang, L. [2 ]
Pirozzi, G. [2 ]
Radin, A. [3 ]
Graham, N. [3 ]
Weinstein, S. [3 ]
Wenzel, S. E. [4 ]
机构：
[1] Washington Univ, Sch Med, St Louis, MO USA
[2] Sanofi, Bridgewater, NJ USA
[3] Regeneron Pharmaceut, Tarrytown, NY USA
[4] Univ Pittsburgh, Asthma Inst, Pittsburgh, PA USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2014年 / 189卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A1321
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Dupilumab in persistent asthma with elevated eosinophil levels
    Bhadresha, Ruksha
    THORAX, 2014, 69 (08)
  • [2] Dupilumab in Persistent Asthma with Elevated Eosinophil Levels
    Wenzel, Sally
    Ford, Linda
    Pearlman, David
    Spector, Sheldon
    Sher, Lawrence
    Skobieranda, Franck
    Wang, Lin
    Kirkesseli, Stephane
    Rocklin, Ross
    Bock, Brian
    Hamilton, Jennifer
    Ming, Jeffrey E.
    Radin, Allen
    Stahl, Neil
    Yancopoulos, George D.
    Graham, Neil
    Pirozzi, Gianluca
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (26): : 2455 - 2466
  • [3] Fev1 Improvement With Dupilumab By Different Baseline Patient Characteristics In Patients With Uncontrolled Persistent Asthma
    Corren, J.
    Spector, S.
    Zhang, B.
    Pirozzi, G.
    Staudinger, H.
    Evans, R. R.
    Graham, N. M. H.
    Louis-Tisserand, M.
    Teper, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [4] Acq5 Improvement With Dupilumab In Patients With Persistent Asthma And Elevated Eosinophil Levels: Responder Analysis From A 12-Week Proof-Of-Concept Placebo-Controlled Trial
    Wenzel, S. E.
    Teper, A.
    Wang, L.
    Pirozzi, G.
    Radin, A.
    Graham, N.
    Castro, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [5] Exposure-Response Analysis of Dupilumab on Forced Expiratory Volume in 1 Second (FEV1) in Uncontrolled Persistent Asthma
    Zhang, Li
    Li, Meng
    Meng, Zhaoling
    Li, Yongtao
    Davis, John D.
    Swanson, Brian N.
    Kanamaluru, Vanaja
    Lu, Qiang
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2017, 44 : S129 - S130
  • [6] DUPILUMAB IMPROVES FEV1 AND EXACERBATIONS IN ASTHMA WITH ALLERGIC RHINITIS
    Weinstein, S.
    Staudinger, H.
    Guillonneau, S.
    Taniou, C.
    Eckert, L.
    Maroni, J.
    Rowe, P.
    Amin, N.
    Pirozzi, G.
    Graham, N.
    Teper, A.
    RESPIROLOGY, 2018, 23 : 154 - 154
  • [7] Association of EDN levels in patients with asthma and correlation with FEV1%: A meta-analysis
    Kuai, Shougang
    Zhao, Peipei
    ALLERGY AND ASTHMA PROCEEDINGS, 2023, 44 (04) : 244 - 251
  • [8] Effect Of Dupilumab On Fev1 And Severe Exacerbations In Patients With Uncontrolled Persistent Asthma: A Subgroup Analysis Defined According To Early-Onset And Late-Onset Asthma
    Weinstein, S. F.
    Ford, L. B.
    Zhang, B.
    Pirozzi, G.
    Staudinger, H.
    Evans, R. R.
    Graham, N. M. H.
    Louis-Tisserand, M.
    Teper, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [9] Reduction In Feno Is Correlated With Fev1 Improvement In Lebrikizumab Treated Asthma Patients
    Cai, F.
    Zheng, Y.
    Holweg, C.
    Choy, D.
    Olsson, J.
    Matthews, J.
    Schereens, H.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [10] High Peripheral Blood Eosinophil (EOS) Levels Are Associated With Low FEV1 Reversibility (REV) In Patients With Severe Eosinophilic Asthma
    Virchow, J. Christian
    Hickey, Lisa
    Garin, Margaret
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2019, 143 (02) : AB6 - AB6
12345